Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 103; no. 9; pp. e404 - e407
Main Authors Aldoss, Ibrahim, Yang, Dongyun, Aribi, Ahmed, Ali, Haris, Sandhu, Karamjeet, Al Malki, Monzr M., Mei, Matthew, Salhotra, Amandeep, Khaled, Samer, Nakamura, Ryotaro, Snyder, David, O’Donnell, Margaret, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.09.2018
Subjects
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Bridged Bicyclo Compounds, Heterocyclic - administration & dosage
Decitabine - administration & dosage
Drug Resistance, Neoplasm
Humans
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - mortality
Leukemia, Myeloid, Acute - pathology
Online Only
Recurrence
Retreatment
Sulfonamides - administration & dosage
Survival Analysis
Treatment Outcome
Online AccessGet full text
ISSN0390-6078
1592-8721
1592-8721
DOI10.3324/haematol.2018.188094

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:0390-6078
1592-8721
1592-8721
DOI:10.3324/haematol.2018.188094